Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Enovis Corporation (ENOV)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
58.26+2.86 (+5.16%)
At close: 04:01PM EDT
58.26 0.00 (0.00%)
After hours: 05:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close55.40
Open55.82
Bid24.15 x 800
Ask93.44 x 1000
Day's Range56.01 - 58.76
52 Week Range54.43 - 94.10
Volume842,270
Avg. Volume590,513
Market CapN/A
Beta (5Y Monthly)2.12
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est136.40
  • Business Wire

    Enovis™, Formerly Branded DJO®, Introduces Arsenal Ankle Plating System™

    WILMINGTON, Del., June 15, 2022--DJO® is now part of the Enovis™ family.* Enovis Corporation, an innovation-driven medical technology growth company, announced today the launch of the Arsenal Ankle Plating System™. This system consists of 37 anatomically designed plates throughout nine plate families, offering a plating solution for any ankle fracture.

  • GlobeNewswire

    Enovis to Participate in the Goldman Sachs Global Healthcare Conference

    Wilmington, DE, June 06, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference on Monday, June 13, 2022. Matt Trerotola, CEO, and Chris Hix, CFO, will be meeting with investors at the conference which is scheduled to take place in Rancho Palos Verdes, California. ABOUT ENOVIS™ Enovis Corporation (NYSE: ENOV) is an innovat

  • GlobeNewswire

    Enovis Announces First Quarter 2022 Adjusted Stand Alone Results

    Wilmington, DE, May 10, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, today announced its adjusted stand-alone financial results for the first quarter of 2022. At the beginning of its second quarter on April 4, 2022, Colfax Corporation spun-off its industrial manufacturing business, ESAB Corporation, in a tax-free distribution to shareholders and renamed itself Enovis. First Quarter Financial

Advertisement
Advertisement